Literature DB >> 21909731

Progressive pathology is functionally linked to the domains of language and emotion: meta-analysis of brain structure changes in schizophrenia patients.

Thomas Nickl-Jockschat1, Frank Schneider, Alena D Pagel, Angie R Laird, Peter T Fox, Simon B Eickhoff.   

Abstract

Schizophrenia is a neuropsychiatric disorder entailing progressive psychotic, cognitive and affective symptoms. Several imaging studies identified brain structure abnormalities in schizophrenia patients, particularly in fronto-temporal regions and evidence for progressive anatomical changes. Here, we synthesised these findings by quantitative coordinate-based meta-analysis, assessing regions of consistently reported brain structure changes, their physiological functions and the correlation of their likelihood with disease duration. The meta-analysis revealed four significant clusters of convergent grey matter reduction, while one cluster indicated higher grey matter values in patients. A voxel-wise analysis revealed a correlation between grey matter reduction and disease duration in the left anterior insula. Functional characterisation revealed significant association with reward, affective processing and language functions. The current analysis allowed the identification of consistent morphometric changes across a large sample of studies in regions that are associated with neurophysiological functions that are altered as hallmarks of schizophrenia psychopathology. The observation that the location of presumably progressive pathology is functionally linked to language and emotion is well in line with increasing deficits in these domains with disease progression in schizophrenia.

Entities:  

Mesh:

Year:  2011        PMID: 21909731      PMCID: PMC5324975          DOI: 10.1007/s00406-011-0249-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  28 in total

1.  Meta-analysis of the functional neuroanatomy of single-word reading: method and validation.

Authors:  Peter E Turkeltaub; Guinevere F Eden; Karen M Jones; Thomas A Zeffiro
Journal:  Neuroimage       Date:  2002-07       Impact factor: 6.556

2.  Minimizing within-experiment and within-group effects in Activation Likelihood Estimation meta-analyses.

Authors:  Peter E Turkeltaub; Simon B Eickhoff; Angela R Laird; Mick Fox; Martin Wiener; Peter Fox
Journal:  Hum Brain Mapp       Date:  2011-02-08       Impact factor: 5.038

3.  A link between the systems: functional differentiation and integration within the human insula revealed by meta-analysis.

Authors:  Florian Kurth; Karl Zilles; Peter T Fox; Angela R Laird; Simon B Eickhoff
Journal:  Brain Struct Funct       Date:  2010-05-29       Impact factor: 3.270

4.  Magnetic resonance imaging of brain in people at high risk of developing schizophrenia.

Authors:  S M Lawrie; H Whalley; J N Kestelman; S S Abukmeil; M Byrne; A Hodges; J E Rimmington; J J Best; D G Owens; E C Johnstone
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

5.  Coordinate-based activation likelihood estimation meta-analysis of neuroimaging data: a random-effects approach based on empirical estimates of spatial uncertainty.

Authors:  Simon B Eickhoff; Angela R Laird; Christian Grefkes; Ling E Wang; Karl Zilles; Peter T Fox
Journal:  Hum Brain Mapp       Date:  2009-09       Impact factor: 5.038

Review 6.  Right hemisphere language functions and schizophrenia: the forgotten hemisphere?

Authors:  Rachel L C Mitchell; Tim J Crow
Journal:  Brain       Date:  2005-03-02       Impact factor: 13.501

7.  Investigating the functional heterogeneity of the default mode network using coordinate-based meta-analytic modeling.

Authors:  Angela R Laird; Simon B Eickhoff; Karl Li; Donald A Robin; David C Glahn; Peter T Fox
Journal:  J Neurosci       Date:  2009-11-18       Impact factor: 6.167

Review 8.  Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence.

Authors:  P J Harrison; D R Weinberger
Journal:  Mol Psychiatry       Date:  2005-01       Impact factor: 15.992

9.  Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

Authors:  Beng-Choon Ho; Nancy C Andreasen; Peg Nopoulos; Stephan Arndt; Vincent Magnotta; Michael Flaum
Journal:  Arch Gen Psychiatry       Date:  2003-06

Review 10.  Emotional face processing in schizophrenia.

Authors:  Richard W Morris; Cynthia Shannon Weickert; Carmel M Loughland
Journal:  Curr Opin Psychiatry       Date:  2009-03       Impact factor: 4.741

View more
  19 in total

Review 1.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

2.  Comparison of structural covariance with functional connectivity approaches exemplified by an investigation of the left anterior insula.

Authors:  Mareike Clos; Claudia Rottschy; Angela R Laird; Peter T Fox; Simon B Eickhoff
Journal:  Neuroimage       Date:  2014-05-17       Impact factor: 6.556

3.  Meta-analytic evidence for altered mesolimbic responses to reward in schizophrenia.

Authors:  Henry W Chase; Polina Loriemi; Tobias Wensing; Simon B Eickhoff; Thomas Nickl-Jockschat
Journal:  Hum Brain Mapp       Date:  2018-03-24       Impact factor: 5.038

4.  Investigating function and connectivity of morphometric findings--exemplified on cerebellar atrophy in spinocerebellar ataxia 17 (SCA17).

Authors:  Kathrin Reetz; Imis Dogan; Arndt Rolfs; Ferdinand Binkofski; Jörg B Schulz; Angela R Laird; Peter T Fox; Simon B Eickhoff
Journal:  Neuroimage       Date:  2012-05-30       Impact factor: 6.556

5.  Task- and resting-state functional connectivity of brain regions related to affection and susceptible to concurrent cognitive demand.

Authors:  Tanja S Kellermann; Svenja Caspers; Peter T Fox; Karl Zilles; Christian Roski; Angela R Laird; Bruce I Turetsky; Simon B Eickhoff
Journal:  Neuroimage       Date:  2013-01-29       Impact factor: 6.556

Review 6.  Structural brain anomalies and chronic pain: a quantitative meta-analysis of gray matter volume.

Authors:  Rachel F Smallwood; Angela R Laird; Amy E Ramage; Amy L Parkinson; Jeffrey Lewis; Daniel J Clauw; David A Williams; Tobias Schmidt-Wilcke; Michael J Farrell; Simon B Eickhoff; Donald A Robin
Journal:  J Pain       Date:  2013-05-17       Impact factor: 5.820

7.  Genetic variation in the G72 gene is associated with increased frontotemporal fiber tract integrity.

Authors:  Thomas Nickl-Jockschat; Tony Stöcker; Axel Krug; Valentin Markov; Ivan I Maximov; Ruiwang Huang; Frank Schneider; Ute Habel; Simon B Eickhoff; Klaus Zerres; Markus M Nöthen; Marcella Rietschel; N Jon Shah; Jens Treutlein; Tilo Kircher
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-07-17       Impact factor: 5.270

8.  Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study.

Authors:  Monika Klirova; Jiri Horacek; Tomas Novak; Jan Cermak; Filip Spaniel; Lucie Skrdlantova; Pavel Mohr; Cyril Höschl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-15       Impact factor: 5.270

9.  Bridging the gap between functional and anatomical features of cortico-cerebellar circuits using meta-analytic connectivity modeling.

Authors:  Joshua H Balsters; Angela R Laird; Peter T Fox; Simon B Eickhoff
Journal:  Hum Brain Mapp       Date:  2013-10-18       Impact factor: 5.038

10.  Neurobiological substrates of the positive formal thought disorder in schizophrenia revealed by seed connectome-based predictive modeling.

Authors:  Ji Chen; Tobias Wensing; Felix Hoffstaedter; Edna C Cieslik; Veronika I Müller; Kaustubh R Patil; André Aleman; Birgit Derntl; Oliver Gruber; Renaud Jardri; Lydia Kogler; Iris E Sommer; Simon B Eickhoff; Thomas Nickl-Jockschat
Journal:  Neuroimage Clin       Date:  2021-04-30       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.